Will Vascepa Train Roll Past Negative Omega-3 Results? STRENGTH, OMEMI temper enthusiasm but may not change much Nov 24, 2020
AHA: Highlighting Effective 'Real-World' Heart Tx Strategies Studies on overcoming GDMT underuse, improving self-care education, creating new settings for care delivery Nov 17, 2020
ANGPTL3 Blocker Halves LDL in High-Risk Group Evinacumab worked in patients refractory to statins, PCSK9 inhibitors Nov 16, 2020
After Stenting, Aspirin May Be Just as Good Solo After 1-Month DAPT Randomized trial makes a case for dropping the P2Y12 inhibitor Nov 15, 2020
Omega-3s Humbled by Corn Oil Placebo in Two Trials Implications for REDUCE-IT's icosapent ethyl unclear Nov 15, 2020
SAMSON Trial: 90% of Statin Complaints Are Nocebo Effect Placebo challenge had positive results for many patients, though Nov 15, 2020
Vascepa Mechanism Becomes Clearer... As Do Vessels Treatment tied to regression of atherosclerosis in imaging-based EVAPORATE Aug 31, 2020
Healthy People 2030: HHS Prioritizes Socioeconomic Disparities, Overall Well-Being New national health goals for the next decade Aug 20, 2020
Jardiance Wins for HFrEF, Farxiga for CKD; COVID Carditis Lingers Recent developments of interest in cardiovascular medicine Aug 04, 2020
Homozygous FH Falls to Praluent, Novel Agent Drugs succeed in cutting LDL in extra-refractory form of high cholesterol Mar 31, 2020
Higher On-Tx EPA Levels Explain Benefit of Vascepa Further evidence from REDUCE-IT that triglyceride lowering is not key to icosapent ethyl's effects Mar 30, 2020
Workplace Wellness Program Triumphs for Hypertension Two-thirds meet blood pressure target after 2 years Mar 04, 2020
LDL Equation May Be Due for Accuracy Upgrade More accurate results seen with new method in certain groups Feb 26, 2020
Ozempic OK'd for CV Prevention; LDL Drug Pricing; Lyme Disease Heart Tx Recent developments of interest in cardiovascular medicine Jan 21, 2020
Is Insurers' Opposition to CAC Scans Softening? The Skeptical Cardiologist explains how one patient got it covered Jan 10, 2020
'Dark Waters': Behind-the-Scenes With Attorney Who Took on DuPont Chemical in Teflon was "completely unregulated" when Robert Bilott went after corporate giant Dec 19, 2019
Algorithm Has Promise for Finding Undiagnosed FH Cleveland Clinic study used EHRs to screen for familial hypercholesterolemia Nov 20, 2019
Vascepa Mechanism Remains Elusive EVAPORATE now must monitor plaque progression out to 18 months Nov 18, 2019
ORION-10: siRNA Tx Halves LDL in Atherosclerotic CVD Manufacturer to start filing for FDA approval for inclisiran Nov 16, 2019
A Cardiologist's Diet Built for Improving Cholesterol The food plan Wesley Milks, MD, adopted to cut his LDL without meds Oct 29, 2019
How Common Are Inaccurate Coronary Artery Calcium Scans? The Skeptical Cardiologist finds reason to suspect the MAC Oct 04, 2019
Big Cuts in LDL Possible With Twice-Yearly Injections siRNA may make for a more convenient lipid-lowering therapy for patients Sep 02, 2019
Drive LDL as Low as Possible, ESC Says New guideline emphasizes more intensive reduction across risk groups Aug 31, 2019
Osteoporosis Drug Wins; Tramadol and Blood Sugar News and commentary from the endocrinology world Aug 30, 2019
AHA Endorses Prescription Fish Oil for High Triglycerides High dose recommended in science advisory Aug 20, 2019
Should the Elderly Discontinue Statins? The debate goes on, but Kevin Campbell, MD, believes every patient is different Aug 14, 2019 video
Low LDL Cholesterol and Hemorrhagic Stroke Another study raises questions about low lipids and ICH Jul 02, 2019
T2D, Cholesterol, and Neuropathy: What's the Link? Lower LDL cholesterol might be a risk factor for nerve damage in type 2 diabetes May 31, 2019
The Alzheimer's-Cholesterol Connection Parallel lines of evidence link the two in early-onset Alzheimer's disease May 28, 2019
Is Stress Testing Warranted for All High Coronary Calcium Scores? A skeptical look at the evidence Mar 27, 2019
Bempedoic Acid: Modest LDL Lowering Affirmed CLEAR Wisdom completes the phase III picture; next step, FDA review Mar 20, 2019
Prescription Fish Oil Goes Beyond Preventing First CV Events New REDUCE-IT data point to secondary prevention benefit Mar 18, 2019
Low-Risk TAVR in Spotlight at ACC Prevention guidelines, Apple Watch also on parade in New Orleans Mar 14, 2019
AHA: Novel Agent Promising for Lowering Lp(a) Levels Treatment with AKCEA-APO(a)-LRx better than placebo at multiple doses Nov 11, 2018
AHA: Zetia May Cut CV Events in Japanese Seniors Results from EWTOPIA75 trial not enough to change practice, experts says Nov 11, 2018
AHA: Prescription Fish Oil Wins for CV Prevention Positive findings for Vascepa in REDUCE-IT trial Nov 10, 2018 video
AHA: Revised Lipid Guide Boosts PCSK9s, Coronary Calcium Scans New recommendations aim to cut statins in low-risk primary prevention Nov 10, 2018 video
AHA: Lipid Guidelines to Headline Meeting Exercise, fish oil, Entresto in acute HF, and an anti-inflammatory also in the spotlight Nov 08, 2018
